Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

FRA/2LYA stock hub

FRA/2LYA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/2LYAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

188.8M

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/2LYA

In the news

Latest news · FRA/2LYA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-39.7

P25 -6.7P50 8.5P75 17.2

ROIC10.5

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/2LYA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

CAD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	DE
Employees	1,832
Employees Change	82%
Employees Change Percent	4.69
Enterprise value	EUR 243.8M
Exchange	Frankfurt Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	CA42981E4013
Last refreshed	2026-05-10
Market cap	EUR 188.8M
Price	EUR 2.12
Price currency	EUR
Rev Per Employee	213,344.16x
Sector	Healthcare
Sic	2834
Symbol	fra/2LYA
Website	https://www.hightideinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.36%
EV Earnings	-8.41x
EV/EBIT	21.81x
EV/EBITDA	9.87x
EV/FCF	19.99x
EV/Sales	0.62x
FCF yield	6.46%
P/B ratio	2.98x
P/S ratio	0.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.86%
EBITDA Margin	4.61%
FCF margin	3.12%
Gross margin	25.8%
Gross Profit	EUR 100.8M
Gross Profit Growth	14.48%
Gross Profit Growth Q	25.31%
Gross Profit Growth3 Y	13.84%
Gross Profit Growth5 Y	31.85%
Net Income	EUR -29M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-7.79%
Profit Margin	-7.42%
Profit Per Employee	EUR -15,830
ROA	3.87
Roa5y	-0.74
ROCE	7.13
ROE	-39.72
Roe5y	-31.95
ROIC	10.54
Roic5y	-0.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.67%
Cagr3y	21.56%
Cagr5y	-19.9%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	-3.97%
FCF Growth3 Y	145.15%
FCF Growth5 Y	23.24%
OCF Growth	-1.06%
OCF Growth Q	759.24%
OCF Growth3 Y	52.47%
OCF Growth5 Y	22.56%
Revenue Growth	17.36x
Revenue Growth Q	25.18x
Revenue Growth Quarters	29x
Revenue Growth Years	7x
Revenue Growth3 Y	16.08x
Revenue Growth5 Y	42.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 2.16
Assets	EUR 215M
Cash	EUR 23.2M
Current Assets	EUR 83.5M
Current Liabilities	EUR 58.2M
Debt	EUR 69.8M
Debt EBITDA	EUR 2.83
Debt Equity	EUR 1.1
Debt FCF	EUR 5.72
Equity	EUR 63.3M
Interest Coverage	1.22
Liabilities	EUR 151.7M
Long Term Assets	EUR 131.5M
Long Term Liabilities	EUR 93.5M
Net Cash	EUR -46.6M
Net Cash By Market Cap	EUR -24.71
Net Debt EBITDA	EUR 2.59
Net Debt Equity	EUR 0.74
Net Debt FCF	EUR 3.82
Tangible Book Value	EUR -24.2M
Tangible Book Value Per Share	EUR -0.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.43
Inventory Turnover	9.63
Net Working Capital	EUR 18.6M
Quick ratio	0.49
Working Capital	EUR 25.3M
Working Capital Turnover	EUR 11.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.67%
200-day SMA	2.33
3Y total return	79.66%
50-day SMA	2.03
50-day SMA vs 200-day SMA	50under200
5Y total return	-67.02%
All Time High	12
All Time High Change	-82.33%
All Time High Date	2021-02-09
All Time Low	0.43
All Time Low Change	397.89%
All Time Low Date	2021-05-13
ATR	0.07
Ch YTD	-4.5
High	2.12
High52	3.41
High52 Date	2025-09-16
High52ch	-37.83%
Low	2.06
Low52	1.8
Low52 Date	2025-08-04
Low52ch	17.52%
Ma50ch	4.38%
Price vs 200-day SMA	-8.9%
RSI	55.25
RSI Monthly	48.9
RSI Weekly	49.1
Sharpe ratio	0.28x
Sortino ratio	0.56
Total Return	-4.55%
Tr YTD	-4.5
Tr1m	8.72%
Tr1w	4.69%
Tr3m	13.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 11.2M
Operating Income Growth	39.46
Operating Income Growth Q	166.2
Operating Income Growth5 Y	64.34
Operating margin	2.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	77,134,881%
Net Borrowing	5,885,273.7
Shares Insiders	8.27%
Shares Institutions	12.2%
Shares Qo Q	2.49%
Shares Yo Y	4.55%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 10.3M
Average Volume	16.95x
Bv Per Share	0.62
CAPEX	EUR -5.8M
Ch1m	8.72
Ch1w	4.69
Ch1y	3.67
Ch3m	13.73
Ch3y	79.66
Ch5y	-67.01
Ch6m	-12.58
Change	2.91%
Change From Open	2.91
Close	2.06
Days Gap	0
Depreciation Amortization	6,845,476.5
Dollar Volume	445.2
Earnings Date	2026-06-12
EBIT	EUR 11.2M
EBITDA	EUR 18M
EPS	EUR -0.35
F Score	3
FCF	EUR 12.2M
FCF EV Yield	5x
Financing CF	4,926,428
Fiscal Year End	October
Founded	2,009
Goodwill	55,864,199.3
Income Tax	EUR -14,272
Investing CF	-13,804,424
Is Primary Listing	0
Last Earnings Date	2026-03-17
Last Report Date	2026-01-31
Last Split Date	2021-05-13
Last Split Type	Reverse
Ma150	2.24
Ma150ch	-5.36%
Ma20	2.02
Ma20ch	5.05%
Net CF	8,087,434
Next Earnings Date	2026-06-12
Open	2.06
P FCF Ratio	15.48
P OCF Ratio	10.47
Position In Range	100
Ppne	49,447,960.7
Price Date	2026-05-08
Price EBITDA	EUR 10.47
Relative Volume	12.39x
Revenue	390,846,508x
SBC By Revenue	0.49x
Share Based Comp	1,931,105
Tax By Revenue	-0x
Tr6m	-12.58%
Volume	210
Z Score	1.84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/2LYA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/2LYA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/2LYA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.2%

Share of float held by funds and institutions

Insider ownership

+8.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.5%

Negative means the company is buying back shares.

Technical

FRA/2LYA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.2

Neutral momentum band

Price vs 200-day MA

-8.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/2LYA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2LYA stock rating?

fra/2LYA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2LYA analysis?

The full report lives at /stocks/fra/2LYA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2LYA?

The latest report frames fra/2LYA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2LYA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.